Alpha Tau Medical Ltd. (NASDAQ:DRTSW) Short Interest Update

Alpha Tau Medical Ltd. (NASDAQ:DRTSW) was the target of a large growth in short interest during the month of May. As of May 15th, there was short interest totaling 13,600 shares, a growth of 285.2% from the April 30th total of 3,531 shares. Based on an average daily volume of 81,908 shares, the short-interest ratio is currently 0.2 days.

Alpha Tau Medical Price Performance

Shares of NASDAQ:DRTSW traded up $0.42 during trading on Friday, hitting $2.80. The company had a trading volume of 41,251 shares, compared to its average volume of 56,095. Alpha Tau Medical has a one year low of $0.20 and a one year high of $2.99. The company has a fifty day simple moving average of $1.39 and a two-hundred day simple moving average of $0.94.

About Alpha Tau Medical

Alpha Tau Medical Ltd. is a clinical-stage medical technology company focused on the development of alpha-emitting radiation therapy for the treatment of solid tumor cancers. The company’s proprietary Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy) platform leverages the short-range, high-energy alpha particles emitted by radium-224 to penetrate tumor tissues more effectively than conventional external-beam radiation. By implanting thin, needle-like sources directly into a tumor, Alpha DaRT delivers concentrated doses of radiation to malignant cells while sparing surrounding healthy tissue.

The Alpha DaRT technology is designed to enhance local tumor control in a variety of solid tumors, including head and neck, breast, skin, and pancreatic cancers.